Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000913849-15-000108
Filing Date
2015-04-09
Accepted
2015-04-09 17:28:02
Documents
1
Period of Report
2015-04-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4_040815.html 4  
1 OWNERSHIP DOCUMENT form4_040815.xml 4 3035
  Complete submission text file 0000913849-15-000108.txt   4753
Mailing Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601
Business Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601 312-899-5034
CVF, LLC (Reporting) CIK: 0001112278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 15762179

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations